Sponsored Content

dsm-firmenich expands its advanced life’s® portfolio with life’sDHA® B54-0100 – a naturally potent DHA algal oil with exceptional sensory appeal

Kaiseraugst (Switzerland), Heerlen (Netherlands), [October 23, 2024]

dsm-firmenich, innovators in health, nutrition, and beauty, has grown its leading-edge life’s® portfolio with the worldwide launch of life’sDHA® B54-0100 – the company’s most naturally potent algal docosahexaenoic acid (DHA) oil to date. The breakthrough ingredient not only meets rising demand for sustainable, plant-based supplements, but also tackles key challenges such as pill fatigue and convenience, making the benefits of DHA available to more consumers globally.

Bringing unmatched potency and sustainability

life’sDHA® B54-0100 delivers 545 mg pure DHA and 80 mg eicosapentaenoic acid (EPA) per gram (equivalent to 620 mg of omega-3 triglycerides), enabling the development of smaller, more cost-effective capsules with higher DHA concentrations. Combined with its superior sensory profile, free from fishy odors and aftertaste, life’sDHA® B54-0100 also opens up new possibilities for more appealing supplement formats, like gummies, chews and candyceuticals – addressing limitations associated with traditional fish-sourced ingredients. Moreover, by sourcing the DHA directly from algae under strictly controlled conditions, dsm-firmenich’s life’sDHA® B54-0100 solution provides a sustainable and contaminant-free alternative.

Addressing global omega-3 deficiency with innovative solutions

“Fish oil supply is not limitless. But algae are. That’s why we introduced life’s® to the market,” comments Brent MacDonald, Business Development Director, Algal Lipids, HNC. “Our mission is to close the omega-3 deficiency gap and ensure that the 80% of the global population currently not meeting daily recommended intake can benefit from these essential nutrients without harming marine life. life’sDHA® B54-0100 can help to achieve exactly that. It brings all the science-based benefits of DHA but at lower inclusion levels, transforms the sensory experience of omega-3 consumption and is good for the planet; making it ideal for applications across the supplement space. Plus, since it's derived from algae, it also offers reliability in cost and supply chain stability.”

In other news…

dsm-firmenich’s commitment to delivering cutting-edge solutions goes from strength to strength, with exciting developments across its entire life’s® portfolio. This includes the milestone introduction of life’s®OMEGA O3020 to the North American market in early 2024, which recently received regulatory approval in EMEA. life’s®OMEGA O3020 is the first and only single-source algal omega-3 with the same EPA-to-DHA ratio naturally found in standard fish oil, but with twice the potency and desirable organoleptic properties. dsm-firmenich has also been developing and will be launching two new highly potent, EPA-rich products in early 2025, further expanding the life’s®portfolio with a range of options that meet consumers’ diverse nutritional needs, health benefits, and format preferences.

For more information on life’sDHA® B54-0100 or the broader life’s® family, visitors to SupplySide West 2024 can drop by booth 4465 to speak to one of dsm-firmenich’s experts. Or, visit here for more information.